Indolent Non-Hodgkin's Lymphomas Active Not Recruiting Phase 1 Trials for Cytarabine (DB00987)

Also known as: Indolent Non-Hodgkin Lymphoma / Indolent Non-Hodgkin's Lymphoma

IndicationStatusPhase
DBCOND0061053 (Indolent Non-Hodgkin's Lymphomas)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02483000Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell MalignanciesTreatment